← FDA Drug Approvals (Drugs@FDA)

BLA761313

BLA · Biologics License Application · Sponsor: HALOZYME THERAP · Approved 2023-06-20

Drug application

FDA Application #

BLA761313

Application type

Biologics License Application

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

HALOZYME THERAP

First approval

2023-06-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown